Increased production of prostaglandin D2 in patients with systemic mastocytosis. Roberts LJ, Sweetman BJ, Lewis RA, Austen KF, Oates JA (1980) N Engl J Med 303: 1400-4 Increased adventitial mast cells in a patient with coronary spasm. Forman MB, Oates JA, Robertson D, Robertson RM, Roberts LJ, Virmani R (1985) N Engl J Med 313: 1138-41 Adenosine A2B receptors. Feoktistov I, Biaggioni I (1997) Pharmacol Rev 49: 381-402 Antibiotics Suppress Activation of Intestinal Mucosal Mast Cells and Reduce Dietary Lipid Absorption in Sprague-Dawley Rats. Sato H, Zhang LS, Martinez K, Chang EB, Yang Q, Wang F, Howles PN, Hokari R, Miura S, Tso P (2016) Gastroenterology 151: 923-932 Adenosine A2b receptors evoke interleukin-8 secretion in human mast cells. An enprofylline-sensitive mechanism with implications for asthma. Feoktistov I, Biaggioni I (1995) J Clin Invest 96: 1979-86 Intervention with epinephrine in hypotension associated with mastocytosis. Turk J, Oates JA, Roberts LJ (1983) J Allergy Clin Immunol 71: 189-92 Neuropeptide Y, a putative cotransmitter in noradrenergic neurons, induces mast cell degranulation but not prostaglandin D2 release. Arzubiaga C, Morrow J, Roberts LJ, Biaggioni I (1991) J Allergy Clin Immunol 87: 88-93 Mast cell-mediated stimulation of angiogenesis: cooperative interaction between A2B and A3 adenosine receptors. Feoktistov I, Ryzhov S, Goldstein AE, Biaggioni I (2003) Circ Res 92: 485-92 Clinical application of PG and TX metabolite quantification. Roberts LJ, Sweetman BJ, Maas RL, Hubbard WC, Oates JA (1981) Prog Lipid Res 20: 117-21 Electrospray ionization mass spectrometry analysis of changes in phospholipids in RBL-2H3 mastocytoma cells during degranulation. Ivanova PT, Cerda BA, Horn DM, Cohen JS, McLafferty FW, Brown HA (2001) Proc Natl Acad Sci U S A 98: 7152-7 Adenosine A2B receptors: a novel therapeutic target in asthma? Feoktistov I, Polosa R, Holgate ST, Biaggioni I (1998) Trends Pharmacol Sci 19: 148-53 Mast cell-mediated inflammatory responses require the alpha 2 beta 1 integrin. Edelson BT, Li Z, Pappan LK, Zutter MM (2004) Blood 103: 2214-20 Novel collectin/C1q receptor mediates mast cell activation and innate immunity. Edelson BT, Stricker TP, Li Z, Dickeson SK, Shepherd VL, Santoro SA, Zutter MM (2006) Blood 107: 143-50 Crosstalk between the alpha2beta1 integrin and c-met/HGF-R regulates innate immunity. McCall-Culbreath KD, Li Z, Zutter MM (2008) Blood 111: 3562-70 Mast cells find their way to the kidney. Eddy AA (2001) Kidney Int 60: 375-7 Hyperadrenergic postural tachycardia syndrome in mast cell activation disorders. Shibao C, Arzubiaga C, Roberts LJ, Raj S, Black B, Harris P, Biaggioni I (2005) Hypertension 45: 385-90 LIPID arrays: new tools in the understanding of membrane dynamics and lipid signaling. Ivanova PT, Milne SB, Forrester JS, Brown HA (2004) Mol Interv 4: 86-96 Identification of skin as a major site of prostaglandin D2 release following oral administration of niacin in humans. Morrow JD, Awad JA, Oates JA, Roberts LJ (1992) J Invest Dermatol 98: 812-5 Integrin alpha2beta1 is required for regulation of murine wound angiogenesis but is dispensable for reepithelialization. Zweers MC, Davidson JM, Pozzi A, Hallinger R, Janz K, Quondamatteo F, Leutgeb B, Krieg T, Eckes B (2007) J Invest Dermatol 127: 467-78 Disruption of lipid order by short-chain ceramides correlates with inhibition of phospholipase D and downstream signaling by FcepsilonRI. Gidwani A, Brown HA, Holowka D, Baird B (2003) J Cell Sci 116: 3177-87 A protective role of mast cells in intestinal tumorigenesis. Sinnamon MJ, Carter KJ, Sims LP, Lafleur B, Fingleton B, Matrisian LM (2008) Carcinogenesis 29: 880-6 Rejection of allogeneic and syngeneic but not MHC class I-deficient tumor grafts by MHC class I-deficient mice. Freland S, Chambers BJ, Andersson M, Van Kaer L, Ljunggren HG (1998) J Immunol 160: 572-9 Prostaglandin D2 generation after activation of rat and human mast cells with anti-IgE. Lewis RA, Soter NA, Diamond PT, Austen KF, Oates JA, Roberts LJ (1982) J Immunol 129: 1627-31 Effects of indomethacin on cyclic nucleotide levels and histamine release from rat serosal mast cells. Lewis RA, Holgate ST, Roberts LJ, Maguire JF, Oates JA, Austen KF (1979) J Immunol 123: 1663-8 Transformation of prostaglandin D2 to isomeric prostaglandin F2 compounds by human eosinophils. A potential mast cell-eosinophil interaction. Parsons WG, Roberts LJ (1988) J Immunol 141: 2413-9 Effect of A2B adenosine receptor gene ablation on proinflammatory adenosine signaling in mast cells. Ryzhov S, Zaynagetdinov R, Goldstein AE, Novitskiy SV, Dikov MM, Blackburn MR, Biaggioni I, Feoktistov I (2008) J Immunol 180: 7212-20 Adenosine-activated mast cells induce IgE synthesis by B lymphocytes: an A2B-mediated process involving Th2 cytokines IL-4 and IL-13 with implications for asthma. Ryzhov S, Goldstein AE, Matafonov A, Zeng D, Biaggioni I, Feoktistov I (2004) J Immunol 172: 7726-33 Effects of prostaglandin D2 on rat serosal mast cells: discordance between immunologic mediator release and cyclic AMP levels. Holgate ST, Lewis RA, Maguire JF, Roberts LJ, Oates JA, Austen KF (1980) J Immunol 125: 1367-73 Environmental pathology. Mast cell and eosinophil infiltration in intestinal mucosa of Lewis rats treated with L-tryptophan implicated in human eosinophilia myalgia syndrome. DeSchryver-Kecskemeti K, Gramlich TL, Crofford LJ, Rader JI, Page SW, Needham LL, Hill RH, Sternberg EM (1991) Mod Pathol 4: 354-7 Host responses to respiratory virus infection and immunization. Crowe JE (1999) Curr Top Microbiol Immunol 236: 191-214 Urticaria pigmentosa. Systemic evaluation and successful treatment with topical steroids. Guzzo C, Lavker R, Roberts LJ, Fox K, Schechter N, Lazarus G (1991) Arch Dermatol 127: 191-6 Mast cell procarboxypeptidase A. Molecular modeling and biochemical characterization of its processing within secretory granules. Springman EB, Dikov MM, Serafin WE (1995) J Biol Chem 270: 1300-7 Correlating Ca2+ responses and secretion in individual RBL-2H3 mucosal mast cells. Kim TD, Eddlestone GT, Mahmoud SF, Kuchtey J, Fewtrell C (1997) J Biol Chem 272: 31225-9 Processing of procarboxypeptidase A and other zymogens in murine mast cells. Dikov MM, Springman EB, Yeola S, Serafin WE (1994) J Biol Chem 269: 25897-904 Inhibition of human mast cell activation with the novel selective adenosine A(2B) receptor antagonist 3-isobutyl-8-pyrrolidinoxanthine (IPDX)(2). Feoktistov I, Garland EM, Goldstein AE, Zeng D, Belardinelli L, Wells JN, Biaggioni I (2001) Biochem Pharmacol 62: 1163-73 Pharmacological characterization of adenosine A2B receptors: studies in human mast cells co-expressing A2A and A2B adenosine receptor subtypes. Feoktistov I, Biaggioni I (1998) Biochem Pharmacol 55: 627-33 Selective, α2β1 integrin-dependent secretion of il-6 by connective tissue mast cells. McCall-Culbreath KD, Li Z, Zhang Z, Lu LX, Orear L, Zutter MM (2011) J Innate Immun 3: 459-70 Role of p38 mitogen-activated protein kinase and extracellular signal-regulated protein kinase kinase in adenosine A2B receptor-mediated interleukin-8 production in human mast cells. Feoktistov I, Goldstein AE, Biaggioni I (1999) Mol Pharmacol 55: 726-34 Cyclic AMP and protein kinase A stimulate Cdc42: role of A(2) adenosine receptors in human mast cells. Feoktistov I, Goldstein AE, Biaggioni I (2000) Mol Pharmacol 58: 903-10 Cross-talk between G(s)- and G(q)-coupled pathways in regulation of interleukin-4 by A(2B) adenosine receptors in human mast cells. Ryzhov S, Goldstein AE, Biaggioni I, Feoktistov I (2006) Mol Pharmacol 70: 727-35
Hints: (1) double-click or double-tap to navigate to a node. (2) Grab a node and move it to arrange the graph.